Reset Map1 Results
8 College Road Singapore, 169857 SingaporeThe beginnings of the Duke-NUS medical school can be traced to 2000, when Singapore launched an ambitious Biomedical Sciences Initiative designed to make the country the biomedical hub of Asia, and to attract both research and health sector manufacturing capabilities to Singapore. In the Initiative, the government planned to spend more than S$3 billion over five years to accelerate development in the biomedical sciences. It offered incentives to attract companies to Singapore, and was funding research institutes devoted to genomics, bioinformatics, bioengineering, nanotechnology, molecular and cell biology, and cancer therapies. In 2001, a Medical Education Review Panel chaired by Lord Oxburgh of England evaluated the plan and recommended that Singapore establish a graduate medical school (Duke-NUS) to produce the highly trained medical leaders needed to support the Biomedical Sciences Initiative. According to the Ministry of Education, the establishment of a graduate-entry medical school will increase the supply of doctors practicing in Singapore, give the country the flexibility to produce more physicians to meet future needs, and train doctors who are exposed to clinically-related research, thus increasing the nation's capacity to develop a vibrant biomedical hub. Duke and the National University of Singapore signed a formal agreement in April 2005 under which the two institutions would partner to establish a new medical school in Singapore. Under the agreement, the Singapore government has made a significant investment over the first seven years to establish Duke-NUS as part of Singapore’s strategy to become a leading centre for medical research and education. Duke-NUS is intended to complement the National University of Singapore's existing undergraduate medical school. Following the exceptionally strong progress in the first phase, on 30 November 2010, the Singapore government signalled their resounding support by extending the Duke and NUS strategic collaboration in education and research by another five years. On 2 June 2016, the Singapore stakeholders further extended this collaboration through a third agreement. The school's curriculum is patterned after that of the Duke University School of Medicine. The school is part of the National University of Singapore system, but unique in that it is overseen by a Governing Board, including a Duke representative who has veto power over any academic decision made by the Board.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.